Valo Therapeutics Ltd
Entity

  • Valo Therapeutics Ltd

    Created in 2016


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    4,959 177

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Viikinkaari 6, 00790 Helsinki, Finland

    Helsinki

    Finland

  • Employees

    Scale: 11-50

    Estimated: 11

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    3 years, 5 months ago
Description
  • Value proposition

    Reinventing Cancer Immunotherapy

    Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.

    immunology, oncology, immunotherapy, and oncolytic viruses

Catalyst interactions
Catalyst Type Tweets Articles
Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto)
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto) 		Other

31 Mar 2025


Social network dynamics
Similar entities
BETA
Last news
Show all articles